BDNF and hepatocellular carcinoma: Specifically, mutations in six neural signaling related pathways, including the neurotrophin signaling pathway, glutamatergic synapse, axon guidance, cholinergic synapse, dopaminergic synapse, and neuroactive ligand-receptor interaction, on average covered 44% of HCC tumors.